Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR
Clinical oncology resident Elabrar Ebrahim shares her experience of having her clinical trial protocol accepted for a prestigious AACR-ASCO workshop. She highlights the importance of mentorship and the inclusion of researchers from low- and middle-income countries in global oncology discussions.
Why it matters
It underscores the importance of global collaboration and mentorship in advancing cancer research and improving healthcare access in resource-limited settings.
Elabrar Ebrahim , Resident clinical oncology at Alexandria University, shared on LinkedIn :
“I am thrilled to share that my clinical trial protocol was accepted for the AACR-ASCO Methods in Clinical Cancer Research Workshop 2026 in Vail , Colorado!
Spending a week surrounded by world leaders in oncology and exceptional early-career investigators was unforgettable – challenging my thinking and sharpening my trial design skills.
As the only oncology fellow attending from a LMIC , I was honored to bring the perspective of researchers working to expand access to high-quality cancer care in resource-limited settings.
A heartfelt thank you to American Association for Cancer Research and American Society of Clinical Oncology (ASCO) for this opportunity.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in